Xinrong Xiang

Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations

Yigang Tang, Huaxin Song, Zhengyuan Wang et al. · Cell Reports · 2022 · 33 citations · Full text

Tumor Biology, Drug Targeting, P53 Mutations +13

Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis

Jing Sui, Wenliang Qiao, Xinrong Xiang et al. · Pharmacological Research · 2022 · 19 citations

Medical Microbiology, Pulmonary Tuberculosis, Health Sciences +15

Rational Design of a Novel Class of Human ClpP Agonists through a Ring-Opening Strategy with Enhanced Antileukemia Activity

Xinrong Xiang, Zhengyi Dai, Baozhu Luo et al. · Journal of Medicinal Chemistry · 2024 · 18 citations · Full text

Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study

Lei Zhao, Jinjun Yang, Mengran Chen et al. · Annals of Hematology · 2024 · 16 citations

Discovery of 5-(Piperidin-4-yl)-1,2,4-oxadiazole Derivatives as a New Class of Human Caseinolytic Protease P Agonists for the Treatment of Hepatocellular Carcinoma

Song Liu, Jing Sui, Baozhu Luo et al. · Journal of Medicinal Chemistry · 2024 · 14 citations · Full text